Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a
- 1 January 1991
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 118 (1), 59-66
- https://doi.org/10.1016/s0022-3476(05)81844-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Successful Treatment of an Angiogenic DiseaseNew England Journal of Medicine, 1989
- Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells.JCI Insight, 1989
- Inhibition of in vitro angiogenesis by lymphotoxin and interferon-γBiochemical and Biophysical Research Communications, 1988
- Gamma-interferon inhibits collagen synthesis in vivo in the mouse.JCI Insight, 1987
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984
- Interferon enhances prostacyclin production by cultured vascular endothelial cells.JCI Insight, 1983
- Inhibition of Cell Motility by InterferonScience, 1980
- Interferon effects on microfilament organization cellular fibronectin distribution, and cell motility in human fibroblastsThe Journal of cell biology, 1980
- Platelet-Derived Growth Factor (PDGF) Inhibits Antiviral and Anticellular Action of Interferon in Synchronized Mouse or Human CellsJournal of Interferon Research, 1980